Articles tagged as "People living with HIV"

People living with HIV

HIV infection and mental health: suicidal behaviour—systematic review

Catalan J, Harding R, Sibley E, Clucas C, Croome N, Sherr L.  Psychol Health Med. 2011 Oct;16(5):588-611.

Suicide has long been associated with serious illness generally and HIV specifically. New treatments have affected prognosis in HIV positively, but it is unclear how they affect suicidal burden (thoughts, self-harm and completions). This review examines all published suicide and HIV data for a definitive account of (1) prevalence of HIV-related suicidality, (2) measurement within studies and (3) effectiveness of interventions. Standard systematic research methods were used to gather quality published papers on HIV and suicide, searching published databases according to quality inclusion criteria. From the search, 332 papers were generated and hand searched resulting in 66 studies for analysis. Of these, 75% were American/European, but there was representation from developing countries. The breakdown of papers provided 12, which measured completed suicides (death records), five reporting suicide as a cause of attrition. Deliberate self-harm was measured in 21, using 22 instruments; 16 studies measured suicidal ideation using 14 instruments, suicidal thoughts were measured in 17, using 15 instruments. Navigating the diverse range of studies clearly points to a high-suicidal burden among people with HIV. The overview shows that autopsy studies reveal 9.4% of deceased HIV+ individuals had committed suicide; 2.4% HIV+ study participants commit suicide; approximately 20% of HIV+ people studied had deliberately harmed themselves; 26.9% reported suicidal ideation, 28.5% during the past week and 6.5% reported ideation as a side effect to medication; 22.2% had a suicide plan; 19.7% were generally “suicidal” (11.7% of people with AIDS, 15.3% at other stages of HIV); 23.1% reported thoughts of ending their own life; and 14.4% expressed a desire for death. Only three studies recruited over 70% female participants (39 studies recruited over 70% men), and six focussed on people who inject drugs. Only three studies looked at interventions – predominantly indirect. Catalan and colleagues’ detailed data suggest that all aspects of suicide are elevated and urgently require routine monitoring and tracking as a standard component of clinical care. There is scant evidence of direct interventions to reduce any aspect of suicidality, which needs urgent redress.

For abstract access click here

Editor’s note: This systematic review of suicidality among people living with HIV found clear gaps in the research database. Only 25% of the studies were from outside the USA, Canada, and Western Europe and only 1% were from sub-Saharan Africa, the region most affected by HIV. Further, there are no standardised definitions of suicidal ideation, suicidal thoughts, and deliberate self-harm, and a wide range of study instruments exists, making it impossible to pool data or compare findings from different studies. What is clear from the literature is that people living with HIV experience higher levels of suicidality, both before and after HIV diagnosis, and the direction of the relationship between HIV serostatus and suicidality is unclear, meaning that we don’t have good evidence to show us which comes first. Further, it is unclear whether the advent of effective antiretroviral therapy has influenced levels of suicidality. More research in low- and middle-income countries and more studies of women are urgently needed. From a direct prevention perspective, health care providers should assess for the presence of suicidal thoughts, active plans, and acts of deliberate self-harm in patients living with or at risk for HIV infection. Critically, there is a striking dearth of information on strategies to reduce suicidality among people living with HIV, an area of obvious concern.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Care and support

Improving the Health and Mental Health of People Living With HIV/AIDS: 12-Month Assessment of a Behavioral Intervention in Thailand

Li L, Lee SJ, Jiraphongsa C, Khumtong S, Iamsirithaworn S, Thammawijaya P, Rotheram-Borus MJ.  Am J Public Health. 2010 Oct 21. [Epub ahead of print]

Li and colleagues examined findings from a randomized controlled intervention trial designed to improve the quality of life of people living with HIV in Thailand. A total of 507 people living with HIV were recruited from 4 district hospitals in northern and northeastern Thailand and were randomized to an intervention group (n=260) or a standard care group (n=247). Computer-assisted personal interviews were administered at baseline and at 6 and 12 months. At baseline, the characteristics of participants in the intervention and standard care conditions were comparable. The mixed-effects models used to assess the impact of the intervention revealed significant improvements in general health (B=2.51; P=.001) and mental health (B=1.57; P=.02) among participants in the intervention condition over 12 months and declines among those in the standard care condition.  The authors’ results demonstrate that a behavioural intervention was successful in improving the quality of life of people living with HIV. Such interventions must be performed in a systematic, collaborative manner to ensure their cultural relevance, sustainability, and overall success.

For abstract access click here:

Editors’ note: The cognitive-based intervention for this trial was informed by pragmatic aspects of Buddhist thought that emphasise personal responsibility, personal betterment, and change in life; by the lived experience of shame and guilt among Thai people living with HIV; and by the family orientation of Thai society. The four modules delivered over 13 weeks were healthy mind, healthy body, parenting and family relationships, and social and community integration. The trial found a significant improvement in both general health and mental health of participants in the intervention arm over a period of 12 months. Those with improved general health were less likely to be depressed or have internalized shame, and were more likely to report positively about family functioning. A significant association was found between mental health and family functioning. The intervention did not have an effect on the physical health of study participants, all of whom were receiving care in district hospitals throughout the study. Two conclusions are that adapting initiatives to the sociocultural context is essential to increasing their potential for impact and that integrating social and psychological components into HIV programmes can improve both individual and family well-being.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Adolescents living with HIV

Undiagnosed HIV Infection among Adolescents Seeking Primary Health Care in Zimbabwe.

Ferrand RA, Munaiwa L, Matsekete J, Bandason T, Nathoo K, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, Corbett EL. Clin Infect Dis. 2010; 51:844-51

Mother-to-child transmission of human immunodeficiency virus (HIV) infection was extremely common in southern Africa during the 1990s, and a substantial minority of infected infants have survived to reach adolescence undiagnosed. Studies have shown a high prevalence of HIV infection in hospitalized adolescents who have features associated with long-standing HIV infection, including stunting and frequent minor illnesses. The authors therefore investigated the epidemiology of HIV infection at the primary care level. Adolescents (aged 10-18 years) attending two primary care clinics underwent HIV and Herpes simplex virus-2 (HSV-2) serological testing, clinical examination, and anthropometry. All were offered routine HIV counselling and testing. Patients attending for acute primary care who were HIV infected were asked about their risk factors. Five hundred ninety-four participants were systematically recruited (97% participation), of whom 88 (15%) were attending for antenatal care. HIV infection prevalence was higher among acute primary care attendees than among antenatal care attendees (17% vs 6%), but for the prevalence of HSV-2 infection, a marker of sexually acquired HIV, the converse was true (4% vs 14%). Seventy (81%) of 86 HIV-positive acute primary care attendees were previously undiagnosed. They had a broad range of presenting complaints, with a median CD4 cell count of 329 cells/muL(interquartile range, 176-485 cells/muL) and a high prevalence of stunting, compared with the corresponding prevalence among HIV-negative attendees (40% vs12%). Maternal transmission was considered to be likely by 69 (80%) of the 86 HIV-positive acute primary care attendees, only one of whom was HSV-2positive. Unrecognized HIV infection was a common cause of primary care attendance. Routine HIV counselling and testing implemented at the primary care level may provide a simple and effective way of identifying older long-term survivors of mother-to-child transmission before the onset of severe immunosuppression and irreversible complications.

For access to full text click here

Editors’ note: Adolescents living in countries with longstanding generalised HIV epidemics should be offered HIV testing and counselling by health care providers, regardless of their presenting complaint. Given the high number of infants infected in the 1990s before the introduction of programmes to prevent mother-to-child transmission and evidence that up to a third may be slower progressors, it is estimated that as much as 1 to 2% of all children aged 10 to 15 years in such settings may have HIV infection. That the vast majority of these children will have been infected through vertical transmission is not in doubt. In this study, there was an equal sex distribution, a strong association with maternal but not paternal orphanhood, and a low prevalence of herpes simplex 2 infection. The latter is an independent marker of sexually acquired HIV because it is a highly prevalent sexually transmitted infection among southern Africans. Finally, Zimbabwe instituted effective polices to stop transmission through contaminated blood and blood products early on in its epidemic. The point is that there are thousands and thousands of undiagnosed young adolescents in southern Africa that could benefit from clinical assessment, prophylaxis for opportunistic illness, and antiretroviral therapy initiation before life-threatening illness and chronic complications announce the possibility of HIV infection, if only they had the chance to learn their serostatus.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Disease progression and alcohol

Alcohol and HIV Disease Progression: Weighing the Evidence.

Hahn JA, Samet JH. Curr HIV/AIDS Rep. 2010 7:226-33

Heavy alcohol use is commonplace among HIV-infected individuals; however, the extent that alcohol use adversely impacts HIV disease progression has not been fully elucidated. Fairly strong evidence suggests that heavy alcohol consumption results in behavioural and biological processes that likely increase HIV disease progression, and experimental evidence of the biological effect of heavy alcohol on simian immunodeficiency virus in macaques is quite suggestive. However, several observational studies of the effect of heavy alcohol consumption on HIV progression conducted in the 1990s found no association of heavy alcohol consumption with time to AIDS diagnosis, while some more recent studies showed associations of heavy alcohol consumption with declines of CD4 cell counts and nonsuppression of HIV viral load. The authors discuss several plausible biological and behavioural mechanisms by which alcohol may cause HIV disease progression, evidence from prospective observational human studies, and suggest future research to further illuminate this important issue.

For full text access click here

Editors’ note: What amount of alcohol intake is too much? The running joke answer is ‘More than what your physician drinks’. This review finds that, although there is strong biological plausibility that heavy alcohol intake might increase the rate of disease progression, it is difficult to demonstrate this in humans. In macaques, alcohol-exposed animals may consume fewer calories from food, have immune activation in the gut, and have higher viral loads at certain times but the association with increased progression of simian immunodeficiency virus infection has not been demonstrated. Heavy alcohol intake in human studies is defined as more than 4 drinks on any one occasion (3 for women) or more than 14 drinks a week (7 for women). Moderate drinking is anything between this level and abstinence. The strongest evidence linking alcohol intake and disease progression is the association between heavy alcohol intake and poor drug adherence. While you wait for scientists to disentangle any biological links between alcohol and disease progression, you can focus on the behavioural one – it would be smart to cut back on your drinking if you are having any trouble taking your medications regularly.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Economics

Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.

Rosen S, Larson B, Brennan A, Long L, Fox M, Mongwenyana C, Ketlhapile M, Sanne I. PLoS One. 2010;5(9):e12731.

Although the medical outcomes of antiretroviral therapy for HIV are well described, less is known about how antiretroviral therapy affects patients' economic activities and quality of life, especially after the first year on antiretroviral therapy. The authors assessed symptom prevalence, general health, ability to perform normal activities, and employment status among adult antiretroviral therapy patients in South Africa over three full years following antiretroviral therapy initiation. A cohort of 855 adult pre- antiretroviral therapy patients and  patients on antiretroviral therapy for <6 months was enrolled and interviewed an average of 4.4  times each during routine clinic visits for up to three years after treatment initiation using an instrument designed for the study. The probability of pain in the previous week fell from 74% before antiretroviral therapy initiation to 32% after three years on antiretroviral therapy, fatigue from 66% to 12%, nausea from 28% to 4%, and skin problems from 55% to 10%. The probability of not feeling well physically yesterday fell from 46% to 23%. Before starting antiretroviral therapy, 39% of subjects reported not being able to perform their normal activities sometime during the previous week; after three years, this proportion fell to 10%. Employment rose from 27% to 42% of the cohort. Improvement in all outcomes was sustained over 3 years and for some outcomes increased in the second and third year. Improvements in adult antiretroviral therapy patients' symptom prevalence, general health, ability to perform normal activities, and employment status were large and were sustained through the first three years on treatment. These results suggest that some of the positive economic and social externalities anticipated as a result of large-scale  treatment provision, such as increases in workforce participation and  productivity and the ability of patients to carry on normal lives, may indeed be accruing.

For full text access click here

Editors’ note: These are encouraging findings – this is the first report to indicate that the benefits of antiretroviral treatment in sub-Saharan Africa, in terms of ability to participate in normal activities, fewer symptoms, and increased employment potential, are sustained to 3 years, well beyond the 12 months documented in the existing small body of literature on antiretroviral treatment and quality of life. The proviso is that these patients were those who continued on antiretroviral treatment in these clinical settings – post-enrolment loss to follow-up was high. Some indicators were slow to increase, for example, the probability of having a job did not increase until about 18 months after starting treatment. But the median CD4 count at treatment initiation was low at 105 cells/mm³, unemployment was high in South Africa at a sustained 24% through the study period, and it takes time to find employment after one becomes capable of working. Further studies will help populate the cost-benefit models that inform our thinking about the positive ‘externalities’ of antiretroviral treatment.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Health care delivery

Task-shifting of antiretroviral delivery from health care workers to persons living with HIV/AIDS: clinical outcomes of a community-based program in Kenya.

Selke HM, Kimaiyo S, Sidle JE, Vedanthan R, Tierney WM, Shen C, Denski CD, Katschke AR, Wools-Kaloustian K. J Acquir Immune Defic Syndr. 2010 Jul. [Epub ahead of print]

The objective of the study was to assess whether community-based care delivered by people living with HIV could replace clinic-based HIV care. This prospective cluster randomized controlled clinical trial was conducted in villages surrounding 1 rural clinic in western Kenya. HIV-infected adults clinically stable on antiretroviral therapy were enrolled. The intervention group received monthly Personal Digital Assistant supported home assessments by people living with HIV with clinic appointments every 3 months. The control group received standard of care monthly clinic visits. The main outcome measures were viral load, CD4 count, Karnofsky score, stability of antiretroviral therapy regimen, opportunistic infections, pregnancies, and number of clinic visits.  After 1 year, there were no significant intervention-control differences with regard to detectable viral load, mean CD4 count, decline in Karnofsky score, change in antiretroviral therapy regimen, new opportunistic infection, or pregnancy rate. Intervention patients made half as many clinic visits as did controls (P < 0.001). Community-based care by people living with HIV resulted in similar clinical outcomes as usual care but with half the number of clinic visits. This pilot study suggests that task-shifting and mobile technologies can deliver safe and effective community-based care to people living with HIV, expediting antiretroviral therapy rollout and increasing access to treatment while expanding the capacity of health care institutions in resource-constrained environments.

For abstract access click here

Editors’ note: This is the first randomised controlled trial to report results on the efficacy of home-based antiretroviral treatment monitoring by people living with HIV who have a secondary school education and are equipped with an electronic decision support tool. The combination of mobile health technologies with task shifting to community care coordinators proved a safe and effective approach to the challenge of human resource constraints in Eldoret, Kenya. The care coordinators assessed patients in their homes monthly using a personal digital assistant that was pre-programmed to collect information on symptoms, vital signs, adherence, food security, and domestic violence. If specific parameters were met, alerts were triggered for the care coordinator to return the next day, transport the patient to hospital, or call to consult the clinical officer. Although the small sample size (96 in intervention group and 112 in the control group) means the study had reduced power to find differences in clinical outcomes, the halving of clinic visits was statistically significant. In addition to rapid replication and evaluation of this approach in other contexts, cost-effectiveness studies are warranted to bring home to programme planners the wisdom of task-shifting that is ‘mobile’ in more than just the geographic sense.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

People living with HIV

Aerobic exercise interventions for adults living with HIV/AIDS.

O'Brien K, Nixon S, Tynan AM, Glazier R. Cochrane Database Syst Rev. 2010 Aug 4;8:CD001796.

Access to combination antiretroviral therapy has turned HIV into a chronic and manageable disease for many. This increased chronicity has been mirrored by increased prevalence of health-related challenges experienced by people living with HIV. Exercise is a key strategy for people living with HIV and recommended by rehabilitation professionals to address these disablements; however, knowledge about the effects of exercise among adults living with HIV still is emerging. The objective of the study was to examine the safety and effectiveness of aerobic exercise interventions on immunologic and virologic, cardiopulmonary, psychological outcomes and strength, weight, and body composition in adults living with HIV. Searches of MEDLINE, EMBASE, SCIENCE CITATION INDEX, CINAHL, HEALTHSTAR, PsycINFO, SPORTDISCUS and Cochrane Review Group Databases were conducted between 1980 and June 2009. Searches of published and unpublished abstracts and proceedings from major international and national HIV conferences were conducted, as well as a hand search of reference lists and tables of contents of relevant journals and books. The authors included studies of randomised controlled trials comparing aerobic exercise interventions with no aerobic exercise interventions or another exercise or treatment modality, performed at least three times per week for at least four weeks among adults (18 years of age or older) living with HIV. Data on study design, participants, interventions, outcomes, and methodological quality were abstracted from included studies by two reviewers. Meta-analyses, using RevMan 5 computer software, were performed on outcomes when possible. A total of 14 studies met inclusion criteria for this review and 30 meta-analyses over several updates were performed. Main results indicated that performing constant or interval aerobic exercise, or a combination of constant aerobic exercise and progressive resistive exercise for at least 20 minutes at least three times per week for at least five weeks appears to be safe and may lead to significant improvements in selected outcomes of cardiopulmonary fitness (maximum oxygen consumption), body composition (leg muscle area, percent body fat), and psychological status (depression-dejection symptoms). These findings are limited to participants who continued to exercise and for whom there were adequate follow-up data. Aerobic exercise appears to be safe and may be beneficial for adults living with HIV. These findings are limited by the small sample sizes and large withdrawal rates described in the studies. Future research would benefit from participant follow-up and intention-to-treat analysis. Further research is required to determine the optimal parameters in which aerobic exercise may be most beneficial for adults living with HIV.

For abstract access click here

Editors’ note: In the general population, exercise improves strength, cardiovascular function, and psychological status. Many people, living with HIV and not, seek improved fitness, well-being, and body image through exercise. This systematic review of the available information on the risks and benefits of exercise for people living with HIV examined trials of aerobic exercise at least 3 times per week. Not only was such exercise safe for five weeks or more, it led to improvements in cardiopulmonary fitness, body composition, and psychological status. There is insufficient information about the effects on women and older people but this does not provide an excuse for sitting around waiting for more data. When considering an unaccustomed exercise programme, it is best to consult one’s health care provider before starting but, after that, people living with HIV can enjoy the benefits of physical fitness and psychological improvements in depression symptoms just as others do. There is no time like the present to get active.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Nutrition

Short-Term Micronutrient Supplementation Reduces the Duration of Pneumonia and Diarrheal Episodes in HIV-Infected Children

Mda S, van Raaij JM, de Villiers FP, Macintyre UE, Kok FJ. J Nutr. 2010; 140:969-74

The duration of pneumonia and of diarrhoea is reported to be longer in HIV-infected than in uninfected children. The authors assessed the effect of a multi-micronutrient supplement on the duration of hospitalization in HIV-infected children. In a double-blind, randomized trial, HIV-infected children (4-24 mo) who were hospitalized with diarrhoea or pneumonia were enrolled (n = 118) and given a daily dose of a multi-micronutrient supplement (containing vitamins A, B complex, C, D, E, and folic acid, as well as copper, iron, and zinc at levels based on recommended daily allowances) or a placebo until discharge from the hospital. Children's weights and heights were measured after enrolment and micronutrient concentrations were measured before discharge. On recovery from diarrhoea or pneumonia, the children were discharged and the duration of hospitalization was noted. Anthropometric indices and micronutrient concentrations did not differ between children who received supplements and those who received placebos. Overall, the duration of hospitalization was shorter (P < 0.05) among children who were receiving supplements (7.3 +/- 3.9 days) (mean +/- SD) than in children who were receiving placebos (9.0 +/- 4.9); this was independent of admission diagnosis. In children admitted with diarrhoea, the duration of hospitalization was 1.6 days (19%) shorter among children receiving supplements than in those receiving placebos, and hospitalization for pneumonia was 1.9 days (20%) shorter among children receiving supplements. Short-term multi-micronutrient supplementation significantly reduced the duration of pneumonia or diarrhoea in HIV-infected children who were not yet receiving antiretroviral therapy and who remained alive during hospitalization.

For abstract access click here:
http://www.ncbi.nlm.nih.gov/pubmed/20335632
Editors’ note: The role of micronutrient deficiency in HIV infection is not well understood and micronutrient supplementation remains controversial. Further, both pneumonia and diarrhoea can cause micronutrient deficiencies. This study of 118 children with HIV infection admitted to hospital for pneumonia or diarrhoea and randomised to receive a micronutrient supplement or placebo found a significantly shorter duration of hospitalisation for those children receiving the supplement. This both decreased their chance of a hospital-acquired infection and freed up a hospital bed earlier for another child. Unfortunately, no baseline micronutrient levels were established before the supplements began so it is impossible to know to what extent the children were micronutrient deficient in the first place. This area clearly deserves further study to confirm these findings. Even more so, it would be useful to determine whether supplementation might reduce the incidence of diarrhoea and pneumonia, both of which are more common in children with HIV infection.
No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Reproductive health

Reproductive choices for women with HIV

Wilcher R, Cates W. Bull World Health Organ. 2009 87:833-9.

Access to reproductive health services for women with HIV is critical to ensuring their reproductive needs are addressed and their reproductive rights are protected. In addition, preventing unintended pregnancies in women with HIV is an essential component of a comprehensive prevention of mother-to-child transmission (PMTCT) programme. As a result, a call for stronger linkages between sexual and reproductive health and HIV policies, programmes and services has been issued by several international organizations. However, implementers of PMTCT and other HIV programmes have been constrained in translating these goals into practice. The obstacles include: (i) the narrow focus of current PMTCT programmes on treating HIV-positive women who are already pregnant; (ii) separate, parallel funding mechanisms for sexual and reproductive health and HIV programmes; (iii) political resistance from major HIV funders and policy-makers to include sexual and reproductive health as an important HIV programme component; and (iv) gaps in the evidence base regarding effective approaches for integrating sexual and reproductive health and HIV services. However, we now have a new opportunity to address these essential linkages. More supportive political views in the United States of America and the emergence of health systems strengthening as a priority global health initiative provide important springboards for advancing the agenda on linkages between sexual and reproductive health and HIV. By tapping into these platforms for advocating and by continuing to invest in research to identify integrated service delivery best practices, we have an opportunity to strengthen ties between the two synergistic fields.

For full text access click here: 1 
Editors’ note:  This ‘must read’ article cogently lays out the human rights and public health arguments for effective linkages and integration of HIV services with sexual and reproductive services. If you have not been convinced that contraceptive use should be an indicator of programmatic success for vertical transmission prevention programmes, you may think twice after reading this article about measuring only the ‘cascade’ which starts with the proportion of women accessing antenatal care services. Women living with HIV need sexual and reproductive health services when they do not wish to become pregnant, when they wish to become pregnant, when they are pregnant and wish to continue their pregnancy, and when they are pregnant and do not wish to continue their pregnancy. As the Convention on the Elimination of all Forms of Discrimination Against Women states: all women have the right ‘to decide freely and responsibly on the number and spacing of their children and to have access to the information, education, and means to enable them to exercise these rights’. A new wind is blowing and it is high time to make both vertical and integrated sexual and reproductive health services priority strategies as we aim to eliminate mother-to-child HIV transmission.
No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

People living with HIV

Suicide in HIV-Infected Individuals and the General Population in Switzerland, 1988-2008.

Keiser O, Spoerri A, Brinkhof MW, Hasse B, Gayet-Ageron A, Tissot F, Christen A, Battegay M, Schmid P, Bernasconi E, Egger M; for the Swiss HIV Cohort Study and the Swiss National Cohort. Am J Psychiatry. 2010. 167:143-150.

High rates of suicide have been described in HIV-infected patients, but it is unclear to what extent the introduction of antiretroviral therapy has affected suicide rates. The authors examined time trends and predictors of suicide in the pre-antiretroviral treatment (1988-1995) and antiretroviral treatment (1996-2008) eras in HIV-infected patients and the general population in Switzerland. The authors analyzed data from the Swiss HIV Cohort Study and the Swiss National Cohort, a longitudinal study of mortality in the Swiss general population. They calculated standardized mortality ratios comparing HIV-infected patients with the general population and used Poisson regression to identify risk factors for suicide. From 1988 to 2008, 15,275 patients were followed in the Swiss HIV Cohort Study for a median duration of 4.7 years. Of these, 150 died by suicide (rate 158.4 per 100,000 person-years). In men, standardized mortality ratios declined from 13.7 (95% CI=11.0-17.0) in the pre-antiretroviral treatment era to 3.5 (95% CI=2.5-4.8) in the late antiretroviral treatment era. In women, ratios declined from 11.6 (95% CI=6.4-20.9) to 5.7 (95% CI=3.2-10.3). In both periods, suicide rates tended to be higher in older patients, in men, in injection drug users, and in patients with advanced clinical stage of HIV illness. An increase in CD4 cell counts was associated with a reduced risk of suicide. Suicide rates decreased significantly with the introduction of antiretroviral treatment, but they remain above the rate observed in the general population, and risk factors for suicide remain similar.

For abstract access click here: 1 

Editors’ note: The results of this study, revealing encouraging declines in the suicide rate among people living with HIV in Switzerland since the advent of antiretroviral treatment, need to be seen in context. Swiss suicide rates are in the top-third in Europe and the top quintile, i.e the top 20%, in the world. Declines in the suicide rate have occurred in the general population too but not to the extent seen in surrounding countries. Switzerland has no national suicide prevention programme to address this important public health problem and the suicide rate among people living with HIV, despite the important declines documented here, may be higher than in other European countries. They are certainly higher than in the general Swiss population and are higher than those in other patients with life-threatening conditions. Although 75% of people with HIV who committed suicide had a diagnosis of mental illness, it is unclear to what extent stigma, discrimination, social isolation, drug toxicity, and other factors are playing roles. Understanding what is influencing decisions to commit suicide is the first step to preventing such unnecessary deaths among people living with HIV.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.